Lambiguit, Noel C.
HRN: 14-29-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/28/2024
01/02/2025
IV
500mg
Q8h
AMOEBIASIS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes